on December 4, 2003
Published online before print December 4, 2003, doi: 10.1161/01.STR.0000105396.93273.72
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 1, 2003
From the Department of Neurology, University of Virginia Health System (D.L.B., K.C.J., E.C.H.), and Department of Health Evaluation Sciences, University of Virginia (K.C.J., D.P.W.), Charlottesville. * To whom correspondence should be addressed. E-mail: devinb{at}umich.edu.
Background and Purpose--In the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study, major neurological improvement within 24 hours (MNI) occurred significantly more frequently with recombinant tissue plasminogen activator (rtPA) treatment than with placebo. We explored the relationship between MNI and 3-month favorable outcome and sought clinical predictors of MNI. Methods--Data from 312 rtPA-treated patients from the NINDS trial were used to assess the ability of MNI to predict favorable outcome at 3 months as defined by a modified Rankin Scale score of 0 to 1. Next, a multivariable predictive model was developed for MNI within the same data set. Clinical variables examined included age, time to treatment (TTT), diabetes, pretreatment glucose, baseline National Institutes of Health Stroke Scale score, pretreatment blood pressure, history of atrial fibrillation, weight >100 kg, and a dense artery sign. Finally, this model was used to forecast into the placebo group of the NINDS trial to assess the uniqueness of the predictors in the rtPA-treated group. Results--MNI had a positive predictive value and negative predictive value of 0.70 for predicting favorable 3-month outcome. Only age [odds ratio (OR), 0.68; 95% confidence interval (CI), 0.47 to 0.99] and TTT (OR, 0.56; 95% CI, 0.34 to 0.91) appear to be independently associated with MNI. The model performed only moderately well (area under the receiver-operating characteristic curve, 0.66). Age (OR, 0.67; 95% CI, 0.45 to 0.99) but not TTT was associated with MNI in the placebo group. Conclusions--MNI may be a useful surrogate for thrombolytic activity and is predictive of favorable 3-month outcome. When rates of MNI in different populations of stroke patients treated with thrombolysis are compared, adjustments for age and TTT may be necessary.
Accepted on September 2, 2003
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Devin L. Brown MD*;
Key words: forecasting • thrombolytic therapy • tissue plasminogen activator • treatment outcome
This article has been cited by other articles:
 |
|
 |
|
  K. C. Johnston, K. M. Barrett, Y. H. Ding, D. P. Wagner, and for the ASAP Investigators Clinical and Imaging Data at 5 Days as a Surrogate for 90-Day Outcome in Ischemic Stroke Stroke, April 1, 2009; 40(4): 1332 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Parsons, F. Miteff, G. A. Bateman, N. Spratt, A. Loiselle, J. Attia, and C. R. Levi Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window Neurology, March 10, 2009; 72(10): 915 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Kharitonova, M Thoren, N Ahmed, J M Wardlaw, R von Kummer, L Thomassen, N Wahlgren, and for the SITS investigators Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 273 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Prabhakaran and M. S.V. Elkind Vive la difference!: On potential sex differences in response to thrombolysis Neurology, September 30, 2008; 71(14): 1048 - 1049. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Smith, G. Sung, J. Saver, R. Budzik, G. Duckwiler, D. S. Liebeskind, H. L. Lutsep, M. M. Rymer, R. T. Higashida, S. Starkman, et al. Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial Stroke, April 1, 2008; 39(4): 1205 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.I. Aviv, J. Mandelcorn, S. Chakraborty, D. Gladstone, S. Malham, G. Tomlinson, A.J. Fox, and S. Symons Alberta Stroke Program Early CT Scoring of CT Perfusion in Early Stroke Visualization and Assessment AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1975 - 1980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mikulik, M. Ribo, M. D. Hill, J. C. Grotta, M. Malkoff, C. Molina, M. Rubiera, R. Delgado-Mederos, J. Alvarez-Sabin, A. V. Alexandrov, et al. Accuracy of Serial National Institutes of Health Stroke Scale Scores to Identify Artery Status in Acute Ischemic Stroke Circulation, May 22, 2007; 115(20): 2660 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.S.V. Elkind, S. Prabhakaran, J. Pittman, W. Koroshetz, M. Jacoby, K. C. Johnston, and for the GAIN Americas Investigators Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke Neurology, March 13, 2007; 68(11): 842 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Y. Bang, J. L. Saver, D. S. Liebeskind, S. Starkman, P. Villablanca, N. Salamon, B. Buck, L. Ali, L. Restrepo, F. Vinuela, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis Neurology, March 6, 2007; 68(10): 737 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Shah, D. S. Liebeskind, J. L. Saver, S. Starkman, F. Vinuela, G. Duckwiler, R. Jahan, D. Kim, N. Sanossian, P. Vespa, et al. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke Neurology, June 13, 2006; 66(11): 1745 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bruno, C. Saha, and L. S. Williams Using Change in the National Institutes of Health Stroke Scale to Measure Treatment Effect in Acute Stroke Trials Stroke, March 1, 2006; 37(3): 920 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yong, H.-C. Diener, M. Kaste, and J. Mau Characteristics of Blood Pressure Profiles as Predictors of Long-Term Outcome After Acute Ischemic Stroke Stroke, December 1, 2005; 36(12): 2619 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saposnik, S. Di Legge, F. Webster, and V. Hachinski Predictors of major neurologic improvement after thrombolysis in acute stroke Neurology, October 25, 2005; 65(8): 1169 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Marti-Fabregas, M. Borrell, D. Cocho, R. Belvis, M. Castellanos, J. Montaner, J. Pagonabarraga, A. Aleu, L. Molina-Porcel, J. Diaz-Manera, et al. Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA Neurology, August 9, 2005; 65(3): 366 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ovbiagele and J. L. Saver The smoking-thrombolysis paradox and acute ischemic stroke Neurology, July 26, 2005; 65(2): 293 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein and D. L. Simel Is This Patient Having a Stroke? JAMA, May 18, 2005; 293(19): 2391 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Haley Jr, P. D. Lyden, K. C. Johnston, T. M. Hemmen, and the TNK in Stroke Investigators A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke Stroke, March 1, 2005; 36(3): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saposnik, B. Young, B. Silver, S. Di Legge, F. Webster, V. Beletsky, V. Jain, Y. Nilanont, and V. Hachinski Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy: Predictors and Association With Outcome JAMA, October 20, 2004; 292(15): 1839 - 1844. [Abstract] [Full Text] [PDF]
|
|